Newsfeeds Archive - Page 35 of 56

2 minute read

Australia’s Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions

February 7, 3:05 PM

As of July 1, psilocybin and MDMA (and related substances to both) can now be prescribed by authorized psychiatrists in Australia, which has become the

NUMIF

1 minute read

Awakn’s Ketamine Treatment For Alcohol Use Disorder Awarded UK’s Fast-Track Status

By Lara Goldstein

February 7, 12:10 PM

Awakn Life Sciences Corp. (OTCQB: AWKNF), a biotech company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), has been granted an Innovation Passport for its proprietary Ketamine-Assisted Therapy (KAT) to treat severe AUD.

AWKNF

5 minute read

Psyched: Australia Legalizes Psychedelics Therapy, BC’s Decrim, State Bills, Millions For Trials & Clinics

By Lara Goldstein

February 6, 3:54 PM

Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as post-traumatic stress disorder and psilocybin for treatment-resistant depression.

CSE:ORIG

4 minute read

EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions

By Lara Goldstein

February 6, 12:00 PM

(Part one of a three-part series)

CMPS

2 minute read

Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded

By Lara Goldstein

February 3, 5:38 PM

Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders

MSSTF

3 minute read

PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch

By Lara Goldstein

February 3, 2:23 PM

Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company's top three news items.

PHRRF

2 minute read

Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents

By Lara Goldstein

February 1, 4:47 PM

After the positive results provided by its clinical trial assessing novel DMT’s effects on patients with Major Depressive Disorder (MDD), psychedelics biotech Small Pharma Inc.

DMTTF

2 minute read

This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea

By Lara Goldstein

February 1, 4:28 PM

Psychedelic-assisted therapy provider, Numinus Wellness Inc.

NUMIF

2 minute read

EXCLUSIVE: Next-Generation Psychedelics, MEAI – The Road Ahead

By Lara Goldstein

February 1, 11:51 AM

(Part four of a four-part series) See previous parts of the series: Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction

CMND